KLIMENTOVA, E.A.,
GILYAZOVA, I.R.,
BERMISHEVA, M.A.,
BLINNIKOVA, A. M.,
SAFIULLIN, R.I.,
IZMAILOV, A.A.,
YANG, B.,
PAVLOV ., V.N,
KHUSNUTDINOVA, E.K. (2020) , which will make it possible both to identify new molecular markers of the risk of developing the
diseaseZagidullin, N.S.,
Dunayeva, A.R.,
Plechev, V.V.,
Gilmanov, A.Z.,
Zagidullin, S.Z.,
Er, F.,
Pavlov, V.N. (2017) of RIPC in coronary heart
disease (CHD) in
9 patients, undergoing CAG, with mild to moderate lowered
Yang, L.,
Luo, W.,
Zhang, Q,
Hong, S.,
Wang, Y.,
Samorodov, A.V.,
Chattipakorn, N.,
Pavlov, V.N.,
Liang, G. (2021) potent anti-inflammatory efficacy in several
disease models, which could be the potential candidates
Tyurin, A.V.,
Salimgareeva, M.K.,
Miniakhmetov, I.R.,
Khusainova, R.I.,
Samorodov, A.,
Pavlov, V.N.,
Kzhyshkowska, J. (2022) levels of NK cell were found in patients with a history of coronary heart
disease (p=0,0108). In addition